» Articles » PMID: 8787138

Ion-channel Defects and Aberrant Excitability in Myotonia and Periodic Paralysis

Overview
Journal Trends Neurosci
Specialty Neurology
Date 1996 Jan 1
PMID 8787138
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The myotonias and periodic paralyses are a diverse group of skeletal muscle disorders that share a common pathophysiological mechanism: all are caused by derangements in the electrical excitability of the sarcolemma. Mutations within coding regions of ion-channel genes have been identified recently as the underlying molecular defects in these heritable disorders. Chloride-channel mutations cause a reduction in the resting conductance, which enhances excitability and gives rise to myotonia. By contrast, missense mutations in the L-type Ca2+ channel reduce the electrical excitability of the fiber and cause a form of periodic paralysis. Mutations of the sodium channel impair inactivation of the channel, which, depending on the type and severity of the functional defect, results in either paralysis or myotonia.

Citing Articles

KCNK1 promotes proliferation and metastasis of breast cancer cells by activating lactate dehydrogenase A (LDHA) and up-regulating H3K18 lactylation.

Hou X, Ouyang J, Tang L, Wu P, Deng X, Yan Q PLoS Biol. 2024; 22(6):e3002666.

PMID: 38905316 PMC: 11192366. DOI: 10.1371/journal.pbio.3002666.


Blockers of Skeletal Muscle Na1.4 Channels: From Therapy of Myotonic Syndrome to Molecular Determinants of Pharmacological Action and Back.

De Bellis M, Boccanegra B, Cerchiara A, Imbrici P, De Luca A Int J Mol Sci. 2023; 24(1).

PMID: 36614292 PMC: 9821513. DOI: 10.3390/ijms24010857.


Large-effect mutations generate trade-off between predatory and locomotor ability during arms race coevolution with deadly prey.

Hague M, Toledo G, Geffeney S, Hanifin C, Brodie Jr E, Brodie 3rd E Evol Lett. 2018; 2(4):406-416.

PMID: 30283691 PMC: 6121790. DOI: 10.1002/evl3.76.


Predominantly myalgic phenotype caused by the c.3466G>A p.A1156T mutation in gene.

Palmio J, Sandell S, Hanna M, Mannikko R, Penttila S, Udd B Neurology. 2017; 88(16):1520-1527.

PMID: 28330959 PMC: 5395072. DOI: 10.1212/WNL.0000000000003846.


Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis.

Corrochano S, Mannikko R, Joyce P, McGoldrick P, Wettstein J, Lassi G Brain. 2014; 137(Pt 12):3171-85.

PMID: 25348630 PMC: 4240299. DOI: 10.1093/brain/awu292.